Not static labels
BioAtlas does not treat hallmarks as a checklist. Each hallmark becomes a biological coordinate that can connect to mechanisms, pathways, cells, metabolic pressure, programmed cell death, immune context, and evidence boundaries.
Hallmark Intelligence
BioAtlas treats cancer hallmarks as structured biological intelligence, not static textbook labels. The public hallmark layer explains how canonical hallmark datasets, six-group hallmark architecture, context weighting overlays, metabolic bridges, programmed cell death context, immune escape, tissue behaviour, pathway pressure, and protected graph intelligence fit together.
24
canonical hallmark datasets
6
hallmark groups
209
public cancer chooser entries
376
protected context weighting overlays
104
hallmark source files
29
Hallmarks dataset files
24
hallmark engine files
22
hallmark-metabolic crosswalks
8
generated hallmark intelligence assets
Cancer behaviour rarely sits inside one mechanism. Hallmarks help BioAtlas organise growth pressure, immune escape, death resistance, invasion, metabolic adaptation, genome instability, identity drift, microenvironment change, and subtype behaviour into a connected review surface.
BioAtlas does not treat hallmarks as a checklist. Each hallmark becomes a biological coordinate that can connect to mechanisms, pathways, cells, metabolic pressure, programmed cell death, immune context, and evidence boundaries.
Hallmarks make cancer behaviour easier to read as a systems-state pattern: what is growing, what is escaping, what is resisting death, what is changing identity, and what is reshaping the tissue environment.
The public hallmark page explains architecture and scope. It does not diagnose cancer, select treatment, prescribe protocols, or expose protected subtype/graph workbench data.
The hallmark estate has been organised into a six-group architecture so public readers can understand the structure without exposing raw workbooks, protected mappings, or internal graph intelligence.
Sustained proliferative signalling, tumour suppressor escape, replication licensing, cell-cycle acceleration, oncogenic pathway pressure, MAPK/PI3K/MTOR context, and proliferative drift.
BioAtlas treats this group as the expansion-pressure domain: the place where growth signals, lost restraint, pathway reachability, and subtype context begin to explain why a tumour system keeps moving forward.
Public pages explain the architecture only. Protected layers may contain subtype-specific weighting, target context, evidence tensors, and graph traversal logic.
Growth signalling, pathway pressure, enzyme regulation, metabolic capacity, regulatory RNA drift, multiomics context, nutrigenetic environment, and oncology subtype behaviour.
Apoptosis resistance, ferroptosis suppression, pyroptosis/necroptosis context, ER stress tolerance, proteostasis, autophagy dependence, mitochondrial persistence, PCD suppression, and stress-adaptation signalling.
BioAtlas reads this group as survival architecture: the logic that lets damaged, stressed, or immune-pressured cells remain viable instead of being cleared through regulated disposal routes.
Public content does not expose clinical prioritisation, protocol selection, dosing logic, or protected PCD graph intelligence.
Programmed cell death, enzyme-controlled survival machinery, pathway compensation, metabolic stress tolerance, cell-state persistence, regulatory RNA, and multiomics escape context.
Immune evasion, checkpoint signalling, tumour-promoting inflammation, cytokine distortion, macrophage context, neuroimmune pressure, complement/chemokine logic, immunotherapy orientation, and host-response misdirection.
BioAtlas frames this group as the host-interface domain: the point where immune surveillance, chronic inflammation, tissue signalling, and tumour adaptation begin to overlap.
Protected systems may contain deeper immune overlays, subtype weighting, clinical context, and reviewed interpretation surfaces.
Host-response distortion, microbiome ecology, immune-cell state, inflammatory enzymes, cytokine pathway pressure, PCD-linked immune visibility, and oncology context.
Altered cellular energetics, hypoxia tolerance, nutrient routing, lactate ecology, redox imbalance, stromal signalling, vascular supply, microbiome influence, tissue ecology, and tumour microenvironment remodelling.
BioAtlas treats this group as the terrain-adaptation domain: cancer behaviour is read through energy demand, local ecology, metabolic pressure, and tissue-level constraints.
Public pages show the conceptual bridge only. Protected systems may contain metabolic overlays, route intelligence, and graph-backed context weighting.
Fuel routing, hypoxia, redox state, nutrient ecology, microbiome influence, enzyme-controlled metabolism, tissue context, and systems-level terrain adaptation.
Phenotypic switching, non-mutational epigenetic reprogramming, chromatin behaviour, miRNA influence, lineage drift, therapy adaptation, cancer stem-cell persistence, intratumour heterogeneity, and identity instability.
BioAtlas reads this group as the identity-control domain: the layer where cell state, epigenetic memory, plasticity, and adaptation explain why one cancer label may contain many behaviours.
Protected depth may include cell-state mappings, miRNA context, subtype logic, and reviewed graph intelligence.
Cell identity, plasticity, chromatin state, regulatory RNA, epigenetic enzyme behaviour, stem-like persistence, PCD selection pressure, nutrigenetic context, and oncology heterogeneity.
Invasion, metastasis, angiogenesis, genome instability, DNA damage response, repair pressure, tissue remodelling, signalling reachability, stromal interaction, and subtype-specific spread behaviour.
BioAtlas frames this group as the spread-and-instability domain: the place where local tumour behaviour becomes systems-level movement, instability, and disease-state reachability.
Public content does not expose protected subtype scoring, drug targeting, patient interpretation, or internal graph workbench outputs.
Subtype behaviour, pathway reachability, enzyme and DNA-repair context, multiomics instability, tissue-state movement, metabolic pressure, and systems spread.
The six-group hallmark architecture is intended for public orientation and scientific review. Protected BioAtlas layers may contain subtype-specific weighting models, graph traversal systems, evidence tensors, target mappings, and governed datasets that are not exposed through this public estate.
BioAtlas currently frames oncology through 24 canonical hallmark-level datasets. These include classical cancer hallmarks plus expanded BioAtlas layers such as phenotypic plasticity, epigenetic reprogramming, tumour microenvironment remodelling, ECS dysregulation, gut microbiome context, immune evasion, DNA repair, heterogeneity, and oncogenic signalling pathways.
Growth signalling, growth suppression escape, immortality, angiogenesis, invasion, metastasis, genome instability, immune escape, inflammation, and altered energetics remain core organising surfaces.
BioAtlas extends the public framing into plasticity, epigenetic reprogramming, tumour microenvironment adaptation, cancer stem-cell persistence, proteostasis, neuroinflammation, ECS dysregulation, microbiome context, DNA repair, heterogeneity, and pathway logic.
The public page summarises the architecture. Deeper mapped rows, context weighting, graph edges, data-room materials, and runtime intelligence remain behind reviewed access.
BioAtlas has generated hallmark context weighting work so cancer subtype context can be read through hallmark pressure rather than a single flat label. This makes hallmark intelligence useful for orientation, diligence, research review, and future protected graph workbenches.
Subtype overlays help BioAtlas connect cancer labels to biological pressure patterns such as proliferation, immune evasion, death resistance, invasion, metabolic adaptation, and tissue remodelling.
A subtype can carry more than one hallmark pressure. BioAtlas therefore treats hallmark weighting as a connected landscape rather than a one-marker classification.
Context weighting is public-safe at the architectural level only. Protected subtype records, scoring logic, exports, and graph traversal remain behind reviewed access.
Hallmark intelligence sits between metabolic adaptation and programmed cell death. It helps explain how tumour systems grow, avoid immune destruction, rewire energy, resist disposal, alter tissue ecology, and maintain persistence.
Hallmark intelligence connects into metabolic reprogramming through cellular energetics, tumour microenvironment pressure, redox behaviour, mitochondrial strain, and subtype-specific metabolic overlays.
Hallmark intelligence connects into programmed cell death by showing where survival, immune visibility, inflammatory death, stress tolerance, autophagy, ferroptosis, apoptosis, and regulated disposal logic interact.
Hallmarks are mapped into oncology subtype context so cancer behaviour can be read through weighted biological pressure rather than a single static cancer label.
Hallmark intelligence has commercial value because it connects cancer behaviour to subtype context, metabolic adaptation, programmed cell death, pathway pressure, molecular targets, biotech relevance, and protected graph infrastructure.
Hallmark records can be used as a graph layer connecting oncology subtypes, mechanisms, cell states, metabolic axes, PCD logic, pathway pressure, and evidence provenance.
Hallmark organisation helps reviewers understand where targets, pathways, drug classes, natural systems, and disease behaviours converge across cancer systems.
Public pages introduce the layer; protected diligence can review graph outputs, commercial packaging, API rights, and data-room material under governed access.
The Hallmark Intelligence public page explains architecture, grouping, public-safe cross-links, and reviewed access pathways. It does not expose raw tables, workbook paths, internal graph files, subtype scoring exports, personal interpretation, treatment advice, dosing, or clinical protocols.